asthenopia
Conditions
Interventions
Experimental Group:Use Jingtongtang cold compress eye patch
Control Group:Use pure water eye patch
Sponsors
Ophthalmology Department of Xiang'an Hospital Affiliated to Xiamen University
Eligibility
Sex/Gender
All
Age
10 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria (All must be met for trial enrollment): (1) Aged 10-50 years (inclusive) regardless of gender; (2) Daily video display terminal (VDT) usage exceeding 4 hours; (3) Presence of at least one of the following asthenopic symptoms: 1) Ocular discomfort: Eye strain ocular pain xerophthalmia burning sensation epiphora ocular pruritus foreign body sensation photophobia nasal root soreness or orbital pain; 2) Visual disturbances: Asthenopia during near work or reading transient blurred vision or diplopia; 3) Systemic symptoms: Fatigue cephalalgia dizziness memory impairment or in severe cases pallor nausea emesis accompanied by anxiety irritability and other neurotic symptoms; (4)Possessing behavioral capacity able to comply with treatment and observation protocols with signed informed consent from both participant and legal guardian (for minors) voluntarily participating in the study.
Exclusion criteria
Exclusion criteria: Exclusion Criteria (All must be met for trial enrollment): (1) Strabismus including intermittent exotropia and any manifest heterotropia; (2) History of ocular surgery; (3) Other ocular diseases affecting visual function such as ocular trauma congenital eye disorders etc.; (4) Current use of ophthalmic solutions (e.g. artificial tears) or other interventions for asthenopia treatment; (5) Severe primary systemic diseases including cardiovascular hepatic renal hematopoietic disorders or systemic autoimmune diseases; (6) History of cutaneous hypersensitivity or known allergy to any component of the trial medications; (7) Participation in other clinical trials within the past 1 month; (8) Other conditions deemed ineligible by the investigator for clinical trial participation.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| relative accommodation;accommodative facility;accommodative response;tear break-up time;conjunctival hyperemia level; | — |
Primary
| Measure | Time frame |
|---|---|
| subjective symptoms; | — |
Countries
China
Contacts
Public ContactZuguo Liu
Eye Institute of Xiamen University
Outcome results
None listed